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Attachment of Sindbis virus to the cell surface glycosaminoglycan heparan sulfate (HS) and the selection of
this phenotype by cell culture adaptation were investigated. Virus (TR339) was derived from a cDNA clone
representing the consensus sequence of strain AR339 (K. L. McKnight, D. A. Simpson, S. C. Lin, T. A. Knott,
J. M. Polo, D. F. Pence, D. B. Johannsen, H. W. Heidner, N. L. Davis, and R. E. Johnston, J. Virol. 70:1981–
1989, 1996) and from mutant clones containing either one or two dominant cell culture adaptations in the E2
structural glycoprotein (Arg instead of Ser at E2 position 1 [designated TRSB]) or this mutation plus Arg for
Ser at E2 114 [designated TRSB-R114]). The consensus virus, TR339, bound to baby hamster kidney (BHK)
cells very poorly. The mutation in TRSB increased binding 10- to 50-fold, and the additional mutation in
TRSB-R114 increased binding 3- to 5-fold over TRSB. The magnitude of binding was positively correlated with
the degree of cell culture adaptation and with attenuation of these viruses in neonatal mice. HS was identified
as the attachment receptor for the mutant viruses by the following experimental results. (i) Low concentrations
of soluble heparin inhibited plaque formation on and binding of mutant viruses to BHK cells by >95%. In
contrast, TR339 showed minimal inhibition at high concentrations. (ii) Binding and infectivity of TRSB-R114
was sensitive to digestion of cell surface HS with heparinase III, and TRSB was sensitive to both heparinase
I and heparinase III. TR339 infectivity was only slightly affected by either digestion. (iii) Radiolabeled TRSB
and TRSB-R114 attached efficiently to heparin-agarose beads in binding assays, while TR339 showed virtually
no binding. (iv) Binding and infectivity of TRSB and TRSB-R114, but not TR339, were greatly reduced on
Chinese hamster ovary cells deficient in HS specifically or all glycosaminoglycans. (v) High-multiplicity-of-
infection passage of TR339 on BHK cell cultures resulted in rapid coselection of high-affinity binding to BHK
cells and attachment to heparin-agarose beads. Sequencing of the passaged virus population revealed a
mutation from Glu to Lys at E2 70, a mutation common to many laboratory strains of Sindbis virus. These
results suggest that TR339, the most virulent virus tested, attaches to cells through a low-affinity, primarily
HS-independent mechanism. Adaptive mutations, selected during cell culture growth of Sindbis virus, enhance
binding and infectivity by allowing the virus to attach by an alternative mechanism that is dependent on the
presence of cell surface HS.
Alphaviruses have a broad host range in nature, replicating
in mammalian, avian, arthropod, and amphibian species, and
are capable of infecting a wide variety of cultured cells (60, 61).
Because of their broad host range, it has been suggested that
alphaviruses use a ubiquitously expressed molecule for attach-
ment to cells (27, 60). Attachment is thought to be mediated
primarily by the virus E2 structural glycoprotein (reviewed in
reference 61). Attached Sindbis virus is uniformly distributed
over fixed cell surfaces, occupying 104 to 105 receptor sites
(similar to results with Semliki Forest virus [SFV] [21]), and
treatment of attached virus with high-ionic-strength buffer re-
sults in the elution of most bound virus (5, 50). These results
suggest that a charge interaction might play a significant role in
alphavirus attachment. Indeed, several studies have suggested
that sulfated polyanions, such as cell surface glycosaminogly-
cans (GAGs), are involved in binding of alphaviruses to cells.
Schleupner et al. (57) implicated polyanionic polysaccharide in
inactivation of a small-plaque variant of Sindbis virus. Syming-
ton and Schlesinger (63) found that pretreatment of mouse
plasmacytoma cells with heparin resulted in a large increase in
Sindbis virus binding. Mastromarino et al. (39) were able to
partially compete Sindbis virus infectivity with soluble heparin
and several other sulfated polyanions and diminish infectivity
by digestion of cell surface heparan sulfate (HS) with hepari-
nase, suggesting that a sulfated molecule may be a component
of the receptor site. Polyanionic compounds which block hu-
man immunodeficiency virus (HIV) attachment also inhibit
infectivity of alphaviruses including SFV and Sindbis virus
(58).
Although a single cellular receptor has not been unambigu-
ously identified for any alphavirus (27, 46; reviewed in refer-
ence 60), studies using methods such as chemical cross-linking
(37), copurification of virus-receptor complexes (16), enzy-
matic inactivation of cellular receptors (59, 69), analysis of
anti-idiotype antibodies (69, 71), and analysis of antireceptor
antibodies (36, 70) have indicated that attachment is mediated
through virus interaction with a cell surface protein. However,
putative receptors of different molecular weights have been
identified in different laboratories and with different cell types
(16, 36, 37, 69–71). Given the number of different cell surface
structures shown to interact with alphaviruses, several investi-
gators have suggested that multiple receptors may exist, in
some instances on the same cell type (59, 69, 70). A significant
complicating factor is that single amino acid differences in the
structural glycoproteins of different strains may profoundly
affect virus attachment-entry processes. As few studies have
compared attachment differences between different alphavirus
* Corresponding author. Mailing address: Department of Microbi-
ology and Immunology, University of North Carolina at Chapel Hill,
School of Medicine, Chapel Hill, NC 27599-7290. Phone: (919) 966-
4026. Fax: (919) 962-8103. E-mail: wklimstr@med.unc.edu.
7357
strains on a single cell type, it is possible that differences
observed in attachment-entry mechanisms may result, at least
in part, from the use of different Sindbis virus laboratory
strains.
Adaptation of Sindbis virus to growth in tissue culture or in
animals has generated virus mutants that can be used to eval-
uate strain-specific differences in receptor usage. Single amino
acid changes in the E2 glycoprotein coordinately alter virus
attachment-entry of cultured cells and pathogenesis in vivo.
Mutations from Ser to Arg at E2 position 114 (11), Glu to Lys
at E2 70 (40, 54), and Gln to His at E2 55 (67) have been
associated with rapid penetration of BHK cells. The mutations
selected in vitro (E2 Lys 70 and E2 Arg 114) are attenuating in
neonatal mice (11, 40, 66), while the in vivo-selected E2 His 55
mutation enhances virulence in older mice (68). A correlation
between in vitro selection for mutations of certain E2 residues
with rapid penetration of BHK cells and attenuation of viru-
lence in vivo also has been shown for other alphaviruses:
S.A.AR86 (54), Venezuelan equine encephalitis virus (VEE)
(13), and SFV (22). However, it remains unknown whether
penetration mutants use the same attachment-entry mecha-
nism as the parental strains from which they were derived.
Also, the effects of preexisting cell culture-adaptive mutations
in parental strains used as genetic background for mutant
selections have not been evaluated. Together, alphavirus re-
ceptor-entry and mutant selection studies have indicated that
while a protein receptor likely plays an important role in the
infection process, charge interactions, perhaps with GAG mol-
ecules, may also contribute to alphavirus attachment.
We have investigated strain-specific differences in Sindbis
virus attachment in a comparative study of virus generated
from cDNA clones of a Sindbis virus AR339 ancestral consen-
sus sequence (TR339) and two cell culture-adapted mutants.
The cloned consensus sequence eliminates several cell culture-
adaptive mutations present in sequenced laboratory strains of
AR339 (40). In our studies, virus differing from the consensus
sequence by either one or two dominant adaptive mutations
exhibited greatly increased binding to BHK cells that was de-
pendent upon the presence of cell surface HS. Binding of
TR339 was only slightly dependent upon HS. The HS-depen-
dent phenotype could be selected rapidly upon passage of
TR339 in BHK cells and was correlated with attenuation of
virus disease in neonatal mice.
(Portions of this work were presented at the 1997 meeting of
the American Society for Virology.)
MATERIALS AND METHODS
Cell culture. Baby hamster kidney (BHK-21) (ATCC CCL-10), Swiss 3T3
(ATCC CCL-92), L929 (ATCC CCL-1), and Neuro-2A (ATCC CCL-131) cells
were maintained in alpha minimal essential medium supplemented with 10%
donor calf serum, 10% tryptose phosphate broth, 0.29 mg of L-glutamine per ml,
100 U of penicillin per ml, and 0.05 mg of streptomycin per ml. Chinese hamster
ovary (CHO-K1) (ATCC CRL-61) and CHO mutant (psgA-745 [ATCC CRL-
2242] and pgsD-677 [ATCC CRL-2244]) cells were maintained in Ham’s F-12
medium supplemented with 10% fetal bovine serum. Primary mouse and chicken
embryo fibroblast (MEF and CEF, respectively) cultures were prepared by ho-
mogenization of 12- to 15-day (MEF) or 9- to 10-day (CEF) gestation embryos
followed by incubation in trypsin for cell dissociation. Dissociated homogenates
were then strained to remove remaining tissue, concentrated through centrifu-
gation, and plated. Cells were grown to confluence and either used directly in
assays or used after one passage. Primary cells were maintained in Dulbecco
minimal essential medium–F-12 supplemented with 10% fetal bovine serum, 100
U of penicillin per ml, 0.05 mg of streptomycin per ml, and 0.05 mg of gentamicin
per ml. All cell culture reagents were obtained from Gibco.
Viruses. All viruses were generated from cDNA clones. The construction of
pTRSB, pE2S1, and pTRSB-R114 (the “p” prefix designates the plasmid form of
the clone) have been described previously (24, 40, 65). pToto 1101 (51), pToto
50 (51), pTE592J (23), and pTE392J (23) were kindly provided by Charles Rice,
Washington University, St. Louis, Mo. pTR339 was constructed in the back-
ground of pE2S1 by introducing the consensus nsP3 Arg 528 through exchange
of an SpeI-to-HpaI fragment from pTE592J and exchange of a BssHII-to-XhoI
fragment from a pToto 1101 clone previously mutagenized to return E1 237 to
the consensus sequence residue (E1 Ala 237). Virus stocks were generated by in
vitro transcription of linearized plasmid DNA followed by electroporation into
BHK cells. To minimize introduction of cell culture-adaptive mutations, super-
natants from electroporated cultures were clarified by centrifugation and used
directly as viral stocks. Stocks were titered by plaque assay on BHK cells.
RP. Replicon particles (RP), similar to those described by Bredenbeek et al.
(6), which contained a Sindbis virus genome with the structural protein genes
replaced by the gene for green fluorescent protein (GFP) were constructed, with
this genome packaged by using various viral E2 glycoproteins. Replicon helper
constructs expressing the capsid and glycoprotein genes but lacking most non-
structural protein sequences and RNA packaging signals were constructed from
plasmids pTRSB, pE2S1, pTR339, and pTRSB-R114 by digestion with SmaI and
HpaI, followed by religation (removing nucleotides 767 to 6991 of the viral
genome). GFP-expressing replicon genomes were constructed by introducing the
mut2 GFP gene (kindly provided by Stanley Falkow, Stanford University) into
the Sindbis virus double 26S promoter vectors pTE592J and pTE392J. The AatII-
to-HpaI restriction fragment of pTE592JGFP was then introduced into pTRSB.
This construct contains a second copy of the 26S subgenomic promoter and the
GFP gene upstream of the authentic 26S promoter but is otherwise isogenic with
pTRSB (pTRSB59GFP). The BsiWI-to-XhoI fragment of pTE392JGFP was like-
wise introduced into pTRSB, creating a downstream double promoter vector
(pTRSB39GFP) with the second 26S promoter and GFP gene just downstream of
the E1 gene. The E1 237 coding difference between pTE392J and pTRSB was
corrected by restriction fragment exchange. PCR primers then were designed to
amplify the GFP gene and surrounding sequences from the downstream GFP
vector, preserving the XhoI site and nontranslated region at the 39 end of the
virus genome and introducing an XbaI site at the 59 end of the GFP gene. The
XbaI-to-XhoI fragment of pTRSB59GFP was removed (deleting all of the struc-
tural genes) and replaced with the PCR fragment, thereby generating a replicon
genome that would produce nonstructural proteins and drive GFP expression in
infected cells from the 26S viral promoter. RP stocks were generated by elec-
troporation of BHK cells with a mixture of GFP replicon and structural protein
helper RNAs. Replicon stocks were titered by fluorescent center assay on BHK
cells. All genetic manipulations described in this and other sections were con-
firmed by DNA sequencing.
Fluorescent center assay. RP were diluted to a concentration of 100 to 200
BHK infectious units per 50 ml in virus diluent-binding buffer (VB) (phosphate-
buffered saline, 1% donor calf serum). Cells were seeded in 12- or 24-well plates
and infected in 50 ml of VB for 60 min at 37°C. Monolayers were washed twice
with VB and incubated in growth medium for 8 to 12 h postinfection. Growth
medium was then removed and monolayers were fixed with 2% paraformalde-
hyde. Individual infected cells expressing GFP were visualized on an Olympus
fluorescence microscope with a fluorescein isothiocyanate filter block.
Plaque reduction assays. Virus was diluted to ;100 BHK PFU per 200 ml in
VB. Cells were infected in 12-well or 60-mm2 plates for 60 min at 37°C. De-
pending upon the experiment, plates were either washed two times with 1 ml of
VB prior to overlay or were overlaid directly with an 0.5% immunodiffusion
agarose-growth medium solution. After 24 h, plates were stained with neutral red
and plaques were enumerated. For competition experiments with heparin, dex-
tran sulfate, chondroitin sulfate A (CS-A), chondroitin sulfate B (CS-B), or
bovine serum albumin (BSA) (all obtained from Sigma), competitor was added
to the diluted virus 30 min prior to infection and the mixture was incubated on
ice. For heparinase I, heparinase III, and chondroitinase ABC (all obtained from
Sigma) digestions, cell monolayers were incubated with the enzyme for 1 h at
37°C, followed by two washes with VB prior to infection.
Virulence of viruses in mice. Neonatal (12- to 24-h-old) CD-1 (Charles River)
mice were infected subcutaneously with 1,000 BHK PFU of each virus in 50 ml
of VB. Virus doses were confirmed by plaque assay of the inoculum on BHK
cells. Mice were observed at 12- or 24-h intervals to determine average survival
times (AST) and percent mortality.
Virus purification. Radiolabeled virus was prepared by infection of BHK cells
with stock virus as described previously (26) with the following modifications.
Virus-infected monolayers were incubated in medium containing 10 mCi of [35S]
methionine (Amersham) per ml. Clarified virus preparations were purified on
discontinuous 20 to 60% (wt/wt) sucrose gradients in TNE (0.05 M Tris-HCl [pH
7.2], 0.1 M NaCl, 0.001 M EDTA) buffer, followed by continuous 20 to 60%
sucrose gradients. For final concentration, virus was pelleted through 20% su-
crose and resuspended in VB. BHK-specific infectivity (PFU per count per
minute [cpm]) was calculated for each radiolabeled virus preparation by plaque
assay on BHK cells.
Virus attachment assay. Due to high background binding of some virus mu-
tants to the surfaces of tissue culture plates, cells were dissociated from plates
with enzyme-free cell dissociation buffer (Gibco) and binding assays were con-
ducted in suspension. Cells were washed three times with VB prior to reaction
with virus. Fifty microliters of cells (;106) were added to Eppendorf tubes
followed by 50 ml of purified virus (ranging from 5 3 104 to 1 3 105 cpm,
equivalent to ;5 3 109 to ;1 3 1010 particles per reaction), each diluted in VB.
Mixtures were incubated at 4°C for 60 min with gentle agitation. Cells then were
washed three times with 1 ml of VB, and pellets were resuspended in 100 ml of
0.6% Nonidet P-40 in TNE. Radioactivity associated with cells was enumerated
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by scintillation counting of 50 ml of the suspension. Control reactions with no
added cells were performed for each binding experiment, and cpm adherent to
reaction tubes were subtracted from total cpm bound. Binding reactions were
performed in duplicate or triplicate, and all experiments were repeated at least
twice. For heparin competition assays, heparin was added to diluted virus 30 min
prior to mixing with cells and incubated at 4°C. For binding to heparin-agarose
beads and BSA-agarose beads (Sigma), 1 ml of beads was washed with VB three
times, followed by resuspension in 1 ml of VB. Fifty microliters of beads was then
added to 50 ml of diluted virus exactly as in the cell binding assays. Incubation,
washes, resuspension, and enumeration of bead-associated radioactivity also
were exactly as with cell binding assays. For GAG precursor addition experi-
ments with psgA-745 cells, monolayers (pgsD-745 and CHO-K1) were incubated
for 48 h in complete medium supplemented with 1 mM p-nitrophenyl-b-D-
galactoxylopyranoside (Sigma) followed by processing for binding assays as de-
scribed above.
BHK-passaged virus. BHK cell monolayers were infected with TR339 at a
multiplicity of infection of ;1, followed by incubation at 37°C for ;20 h. Su-
pernatants were harvested and clarified as with viral stocks and then titered and
used for infection of a new BHK monolayer. This was repeated until five pas-
sages had been achieved. For radiolabeling of BHK-passaged virus, clarified
supernatants of passage 2 virus were used to infect BHK cell monolayers fol-
lowed by processing, as described above. This resulted in production of radio-
labeled virus particles with a passage level equivalent to passage 3. Virus genome
RNA was harvested directly from the third BHK cell passage supernatant by
extraction with RNAzol (Bio 101), followed by isopropanol precipitation. RNA
was then subjected to reverse transcriptase PCR with E2 and E1 glycoprotein-
specific primers on a Perkin-Elmer Cetus thermocycler. The cDNA was then
amplified by PCR with the same primer sets. Amplified cDNA was sequenced at
the University of North Carolina at Chapel Hill Automated DNA Sequencing
Facility on a model 373A DNA sequencer (Applied Biosystems) with the Taq
DyeDeoxy Terminator Cycle Sequencing Kit (Applied Biosystems).
RESULTS
A cDNA clone (designated pTR339) of the ancestral Sindbis
virus AR339 sequence (40) has been constructed. This se-
quence differs from the clone of our biological laboratory
strain of AR339 (pTRSB) at three coding positions: nsP3 528,
E2 1, and E1 72 (Table 1). The biological isolate which was the
source for pTRSB was derived by single-step selection for
growth in BHK cells (40). An Arg-for-Ser substitution at E2
114, conferring rapid penetration of BHK cells in comparison
with TRSB and significantly attenuating virulence, was selected
in the TRSB background and incorporated into pTRSB to
give pTRSB-R114 (11, 65). We have used TR339, TRSB, and
TRSB-R114 in mouse virulence, cell binding, and infectivity
assays to determine if adaptation to BHK cells is correlated
with altered cell attachment and changes in virulence for neo-
natal mice.
Virulence of viruses for neonatal mice. Twelve- to 24-h-old
CD-1 mice were inoculated subcutaneously with each virus and
monitored for mortality at 12-h intervals (Fig. 1). Infection
with TR339 resulted in 100% mortality, with an AST of 1.8 6
0.34 (mean 6 standard deviation) days. TRSB infection also
resulted in 100% mortality, but the AST was extended signif-
icantly (3.2 6 0.46 days [two-tailed Student’s t test with un-
equal variance; P, ,0.001]). TRSB-R114 caused only ;50%
mortality, with a considerably extended survival time (7.9 6 2.5
days). These data indicate that strains which diverge at only
one or two amino acids from the AR339 consensus sequence
can exhibit significant attenuation of disease in neonatal mice.
Virus binding to and infectivity for BHK cells. BHK cell
binding assays revealed a dramatic difference in attachment
efficiencies of TR339 and the cell culture-adapted mutants
(Fig. 2). In multiple experiments, only 0.05 to 0.5% of added
TR339 bound to BHK cells, while the bound proportion of
added TRSB and TRSB-R114 increased to 5 to 10% and 20 to
30%, respectively. These results suggest a strong correlation
between BHK cell-adaptive mutations and attachment effi-
ciency and an inverse correlation with virulence in mice. We
have also found this correlation with other AR339 strains (33).
For TR339, the percent cpm bound was much lower than
previously reported for AR339 laboratory strains (59, 67, 69,
70). Preliminary assays indicated that the binding of TR339
and TRSB to BHK cells was not saturable. However, TRSB-
R114 exhibited saturable binding (data not shown).
Specific infectivity of radiolabeled virus (PFU/cpm) was
closely correlated with relative binding to BHK cells (Fig. 2).
Covariation of binding and infectivity suggests that binding
measured in these assays reflects an interaction that leads
FIG. 1. Survival of neonatal CD-1 mice infected with TR339 (solid line; n, 30;
AST, 1.8 6 0.34 days), TRSB (evenly dashed line; n, 30; AST, 3.2 6 0.46 days),
or TRSB-R114 (unevenly dashed line; n, 25; AST, 7.9 6 2.5 days). Mice were
inoculated subcutaneously with 1,000 BHK PFU of virus in 50 ml of diluent.
FIG. 2. Relative binding and specific infectivity of TR339, TRSB, and TRSB-
R114 for BHK cells. For binding assay (solid bars), 105 cpm of each radiolabeled
virus was added to 106 BHK cells in suspension and incubated at 4°C for 60 min.
After three washes with VB, radioactivity associated with cells was quantitated.
For specific infectivity (hatched bars), radiolabeled virus was diluted and assayed
for plaque formation on BHK cell monolayers. Specific infectivity (PFU/cpm)
was then calculated for each virus. Values are presented as percentages of values
for TRSB (100%). p, binding of TR339 was ,1% of that of TRSB in this assay.
TABLE 1. Amino acid differences of viruses used in the
present studies
Virusa
Amino acid position in glycoprotein sequence
nsP3 528 E2 1 E2 114 E1 72
TR339 Arg Ser Ser Ala
E2S1 Gln Ser Ser Val
TRSB Gln Arg Ser Val
TRSB-R114 Gln Arg Arg Val
E2S1-R114 Gln Ser Arg Val
a Viruses were derived from cDNA clones that are isogenic except for the
indicated loci.
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directly to infection of cells and that the increase in infectivity
of TRSB compared with TR339, and the additional increase of
TRSB-R114 compared with TRSB, results from increased ef-
ficiency of attachment to cells. Binding reactions with primary
CEF, primary MEF, murine L929 fibroblasts, murine Swiss
3T3 fibroblasts, and murine Neuro-2A neuroblastoma cells
revealed the same patterns of binding efficiency as with BHK
cells: TRSB-R114 . TRSB . TR339 (data not shown). The
absolute amount of binding for each virus varied between cell
types; however, TR339 binding was never more than 1% of
added cpm.
Binding and BHK cell infectivity of a virus with Ser at E2 1,
but the TRSB residues at nsP3 528 and E1 72 (E2S1) (Table
1), were indistinguishable from TR339 (data not shown). This
demonstrates that of the three TRSB mutations relative to the
consensus sequence (Table 1), the E2 Arg 1 mutation alone
accounts for the increased binding and infectivity.
We also placed the E2 Arg 114 mutation in the E2 Ser 1
background (E2S1-R114) (Table 1). The resultant virus exhib-
ited .90% of the binding efficiency of TRSB-R114 (data not
shown). This suggests that the E2 Arg 114 mutation by itself
confers a very large increase in attachment ability and that the
E2 Arg 1 and E2 Arg 114 mutations can independently in-
crease cell binding.
Heparin competition of binding and infectivity. As de-
scribed above, several previous Sindbis virus studies indicated
that a charge-based interaction, perhaps involving a cell sur-
face sulfated polysaccharide, might be important to binding. In
preliminary assays, we found that the binding and infectivity of
TR339 were insensitive to ionic strength, whereas TRSB and
TRSB-R114 binding and infectivity were significantly reduced
by NaCl concentrations above 175 mM (data not shown). This
indicated that alteration of cell surface charge could affect the
binding of BHK cell-adapted Sindbis virus strains.
We next evaluated the ability of the sulfated polysaccharide
heparin to block plaque formation by these viruses (Fig. 3A).
Virus derived from pToto 50 (cDNA clone of Sindbis virus
strain HRsp [51]) also was included to evaluate the effects of
heparin on the infectivity of an extensively passaged AR339
strain. Heparin is commonly used as an analog of cellular HS
in receptor-ligand interaction assays, since ligand interactions
with heparin and analogous HS structures have little qualita-
tive difference (31). TR339 showed only limited (;25%) com-
petition at heparin concentrations ranging from ,50 mg/ml to
.10 mg/ml. In sharp contrast, soluble heparin effectively com-
peted infectivity of TRSB and TRSB-R114 at low concentra-
tions (50% plaque reduction endpoints of 1.1 and 3.3 mg/ml,
respectively [Fig. 3A]). Plaque formation by Toto 50 also was
.95% competed; however, the 50% plaque reduction end-
point was at a 5- to 10-fold-higher heparin concentration than
for TRSB and TRSB-R114. In control competition experi-
ments, BSA slightly increased plaque numbers with increasing
concentrations, while the GAG molecule CS-A had no detect-
able effect on infectivity of any of the viruses. CS-B (dermatan
sulfate), which is structurally similar to HS, and dextran sul-
fate, a highly sulfated molecule similar to heparin, inhibited
virus plaque formation only at high concentrations (.1 mg/ml
[data not shown]).
It is of interest that maximum competition of TR339 was
achieved at ,50 mg of heparin per ml, with no further increase
in competition observed at 10 mg/ml. This result may indicate
the presence of two populations of virus in the TR339 stock.
Production of virus stocks by electroporation of in vitro tran-
scripts may involve limited selection for growth on BHK cells
(see below). If electroporation efficiency is less than 100%,
then virus progeny from successfully electroporated cells will
be amplified in cells that received no viral transcripts initially.
Binding assays showed a similar pattern, in that TRSB and
TRSB-R114 were competed in binding by soluble heparin
while TR339 showed resistance similar to that exhibited for
plaque formation (Fig. 3B). However, concentrations required
to inhibit binding of the viruses were significantly greater than
for plaque reduction, likely reflecting the much higher concen-
tration of virus used in binding assays. Consistent with plaque
formation assays, BSA increased binding slightly and CS-A had
no effect. These results indicate that the block in generating
TRSB or TRSB-R114 plaques in the presence of heparin is at
the level of attachment to cells.
Enzymatic digestion of cell surface HS. Heparinase diges-
tion of cells is commonly used to examine the effect of removal
of HS on ligand binding to cell surface receptors (53). Virus
infectivity and binding were evaluated after digestion of BHK
cells with heparinase I (which digests highly sulfated heparin-
like structures on HS [15]) or heparinase III (which digests
FIG. 3. Soluble heparin competition of TR339, TRSB, TRSB-R114, and
Toto 50. (A) Reduction in plaque formation of TR339 (squares), TRSB (circles),
TRSB-R114 (triangles), and Toto 50 (diamonds) on BHK cell monolayers with
increasing concentrations of heparin. Viruses were diluted to 100 to 200 PFU/200
ml and reacted with heparin for 30 min at 4°C, followed by infection of BHK cell
monolayers in the presence of heparin. (B) Reduction in binding of TR339
(squares), TRSB (circles), and TRSB-R114 (triangles) to BHK cells with increas-
ing concentrations of heparin. Viruses (105 cpm/reaction) were reacted with
heparin as described above, followed by binding assay in the presence of heparin.
Results are averages of two or three reactions at each concentration.
7360 KLIMSTRA ET AL. J. VIROL.
both HS and heparin [15]). Digestion of BHK cells with in-
creasing concentrations of either heparinase I or III resulted in
a maximum reduction of TR339 infectivity of only ;25% re-
gardless of the enzyme used, consistent with the heparin com-
petition experiments (Fig. 4). However, a dose-dependent in-
hibition of TRSB plaque-forming ability was observed with
both heparinase I and heparinase III. TRSB-R114 was unaf-
fected by heparinase I digestion; however, this virus was nearly
as sensitive as TRSB to heparinase III.
Binding experiments were consistent with efficiency of plaque
formation. Binding of TRSB was sensitive to both heparinase
I and heparinase III, while TRSB-R114 was sensitive only to
heparinase III (Fig. 5). In control experiments, binding and
infectivity of all viruses were reduced significantly less (maxi-
mum of ;30% reduction) by digestion of cells with chondroiti-
nase ABC (data not shown). These heparinase experiments
suggest that TRSB and TRSB-R114 interact with different
types of HS structures. TRSB-R114 binding may be dependent
on a structural characteristic of HS or the context of HS dis-
played on cell surfaces, while TRSB may bind promiscuously to
HS structures. The fact that TRSB-R114 binding is saturable,
while that of TRSB is not, also suggests that these viruses at-
tach to different HS structures.
Genetic alteration of cell surface GAGs. Binding and infec-
tivity of viruses also were evaluated on wild-type CHO-K1 cells
and CHO mutants defective in GAG and HS synthesis. The
mutant CHO cell line pgsA-745 is deficient in xylosyltrans-
ferase (18), an enzyme of a pathway common to all GAG
biosynthesis, and hence is GAG deficient. The mutant line
pgsD-677 is deficient in N-acetylglucosaminyl- and glucuronos-
yltransferase activities (interrupting HS synthesis) and over-
produces CS (35). Due to extremely variable plaque sizes of
Sindbis virus on the different CHO cell lines, an RP-based
fluorescent infectious center assay was used to determine in-
fectivity on these cells. Cell monolayers were infected with RP
assembled with structural proteins of either TR339, TRSB, or
TRSB-R114 and containing a defective genome that directed
the expression of GFP within infected cells. Since structural
protein genes were deleted from the RP genomes, virus spread
beyond the initially infected cells was prevented. Therefore,
relative RP infectivity, determined by the TR339, TRSB, and
TRSB-R114 glycoproteins in their respective envelopes, could
be measured by enumeration of single infected cells by fluo-
rescence microscopy.
Consistent with the role of GAGs suggested by the compe-
tition and enzymatic digestion assays, the infectivity of TRSB
FIG. 4. Effect of heparinase digestion on plaque-forming efficiency of TR339,
TRSB, and TRSB-R114 on BHK cells. (A) BHK cell monolayers were digested
with increasing concentrations of heparinase I, followed by three rounds of
washing with virus buffer and infection with 100 to 200 PFU of TR339 (squares),
TRSB (circles), or TRSB-R114 (triangles). (B) BHK cell monolayers were di-
gested with increasing concentrations of heparinase III, washed, and infected as
above. Data are averages of two or three assays at each concentration.
FIG. 5. Effect of heparinase digestion on binding of TRSB (circles) and
TRSB-R114 (triangles) to BHK cells. (A) BHK cell monolayers were digested
with increasing concentrations of heparinase I, followed by three rounds of
washing with VB, suspension, and use in binding assays (5 3 104 cpm of radio-
labeled virus per reaction). (B) BHK cell monolayers were digested with increas-
ing concentrations of heparinase III and processed as above. Data are averages
of two or three binding reactions at each concentration. In these assays, binding
of TR339 to digested or undigested cells was not above background cpm mea-
sured in cell-free control reactions.
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and TRSB-R114 RP was greatly reduced on the GAG-defi-
cient cells (by 90 and .95%, respectively [Fig. 6A]). Reminis-
cent of heparinase digestion of BHK cells, TR339 RP exhibited
only ;30% reduction in infection efficiency. Infectivity of mu-
tant RP on the HS-deficient pgsD-677 cells was greatly re-
duced compared to wild-type cells but was not reduced as
much as with GAG-deficient cells (Fig. 6A). However, this
difference between the two cell lines appears to be unrelated to
cell binding (see below).
In close correlation with infectivity, binding of TRSB and
TRSB-R114 to the GAG-deficient pgsA-745 cells was reduced
by .90 and .95%, respectively, compared with CHO-K1 cells
(Fig. 6B). Binding of the mutant viruses to the HS-deficient
pgsD-677 cells was similarly reduced; however, as indicated
above, all RP were slightly more infectious for these cells,
suggesting that overproduction of CS may increase infection
efficiency at a postbinding step of virus entry. In addition,
binding to the mutant pgsD-677 cells was consistently lower
than to pgsA-745 cells, suggesting either that the pgsA-745
cells produce a small amount of HS or that the overproduction
of CS on pgsD-677 cells inhibits virus binding. In the absence
of GAGs or HS, the amount of binding of TRSB and TRSB-
R114 was reduced to the level of TR339 binding. This indicates
that interaction with HS accounts for most, if not all, of the
increased binding and infectivity of TRSB and TRSB-R114 on
normal cells relative to TR339.
The specific effect of HS-GAG deficiency on binding to
pgsA-745 cells was further shown by restoring GAG precursors
to these cells. The pgsA-745 cells cannot transfer xylose pre-
cursors to core proteins to initiate GAG chain synthesis (18).
The addition of xyloside precursors increases production of
GAGs in these cells to a level similar to precursor-treated
CHO-K1 cells and restores binding of the HS binding-depen-
dent basic fibroblast growth factor (17). However, GAGs pro-
duced under these conditions are not covalently attached to
core proteins and may adhere to cell surfaces as free GAG
chains (49). Incubation of pgsA-745 cells in 1 mM p-nitrophe-
nyl-b-D-galactoxylopyranoside for 48 h resulted in the restora-
tion of TRSB binding to .90% of TRSB binding to similarly
treated CHO-K1 cells. However, TRSB-R114 binding was re-
stored only to ;20% of TRSB-R114 binding to similarly
treated CHO-K1 cells (data not shown). This result, in com-
bination with the heparinase digestion and binding saturation
studies, suggests that TRSB binds promiscuously to HS mole-
cules on cell surfaces. In contrast, the majority of TRSB-R114
binding may be dependent on a subset of HS, perhaps requir-
ing attachment of these molecules to proteoglycan core pro-
teins. Separate control experiments demonstrated that, like
BHK cells, binding and infectivity of TRSB and TRSB-R114
(but not TR339) on wild-type CHO-K1 cells were efficiently
competed with soluble heparin. In addition, CHO-K1 cells
showed reductions in binding and infectivity similar to BHK
cells after digestion with heparinases (data not shown).
Direct virus binding to an HS analog. To determine whether
TRSB and TRSB-R114 bind directly to HS structures, heparin-
agarose and BSA-agarose beads were used as cell surrogates in
suspension binding assays. Results shown in Table 2 demon-
strate that both mutant viruses bound efficiently to heparin-
agarose beads, while TR339 did not. In contrast to cell binding
assays, the beads bound ;70% of TRSB and TRSB-R114 ra-
dioactivity added. The actual binding in these assays may have
been even greater, since there was some unavoidable loss of
beads during wash steps. None of the viruses bound apprecia-
bly to BSA-agarose beads (Table 2), and binding of TRSB and
TRSB-R114 to the heparin-agarose beads could be competed
with soluble heparin but not soluble BSA or CS-A (data not
shown). These results taken together strongly indicate that
attachment to heparin-agarose beads results from a specific
virus-heparin interaction. The E2S1-R114 virus (Table 1) also
attached efficiently to heparin-agarose beads (Table 2), sug-
gesting that the E2 Arg 114 mutation defines a separate locus
(compared with E2 1) capable of independently mediating HS
attachment.
Passage of TR339 in BHK cells coselects for increased cell
binding and heparin interaction. Mutation to efficient HS at-
tachment is the result of active selection pressure during Sind-
bis virus adaptation to BHK cell growth. As with the other
FIG. 6. Infectivity of TR339, TRSB, and TRSB-R114 GFP-expressing RP
and binding of analogous viruses to wild-type CHO-K1 cells and CHO cell mu-
tants deficient in all GAGs (pgsD-745) or HS (pgsD-677). (A) Monolayers of
each cell type were infected (60 min) with 100 to 200 BHK GFP-infectious units
followed by three washes with VB, medium replacement, and incubation for 8 to
12 h. Cells expressing GFP were enumerated by fluorescence microscopy. Data
are averages of four infections of TR339 (hatched bars), TRSB (solid bars), and
TRSB-R114 (cross-hatched bars). (B) Suspension binding assays (105 cpm added
per reaction) were completed as described for BHK cells. Results for TR339
(hatched bars), TRSB (solid bars), and TRSB-R114 (cross-hatched bars) are pre-
sented as percent cpm bound and represent averages of two or three reactions.
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experiments reported here, the TR339 stock (passage 0) con-
sisted of culture fluids from cells electroporated with in vitro
transcripts of a full-length cDNA clone. TR339 was passaged
five times in BHK cells, followed by assay of the attachment
phenotype of virus obtained from each passage. Figure 7A
shows increasing virus titer and susceptibility to competition
with soluble heparin (200 mg/ml) for virus from passages 1
through 5. Between passage 1 and passage 3, virus titer in-
creased ;100-fold, concomitant with an increase in suscepti-
bility to heparin competition of from ;20 to .80%. No further
increase in either phenotype was noted after passage 3. For
this reason, virus equivalent to passage 3 was used for subse-
quent analysis. Radiolabeled virus binding assays indicated
that one consequence of the adaptation of TR339 to BHK cells
was a large increase in binding to and specific infectivity for
BHK cells (Fig. 7B). In fact, binding and infectivity of the
passage 3 virus was significantly greater than TRSB and similar
to TRSB-R114 (Fig. 2 and 7B). The passage 3 virus also at-
tached efficiently to heparin-agarose beads, indicating that
heparin binding and cell binding were covariant phenotypes
(Fig. 7C). The E1 and E2 glycoproteins of the passage 3 virus
population were sequenced, and a single coding change from
Glu to Lys at E2 70 was found. This mutation was observed
previously in our laboratory during BHK cell passage experi-
ments (40, 54). It also is a constituent of most Sindbis virus
AR339 laboratory strains, including Toto 50, which is effec-
tively competed by soluble heparin. Similar to the effect of E2
Arg 114, E2 Lys 70 confers rapid penetration of BHK cells
when introduced into the TRSB (E2 Arg 1) background and
significantly attenuates virulence in neonatal mice (40).
DISCUSSION
HS as a Sindbis virus attachment receptor. HS can serve as
an attachment receptor for Sindbis virus but contributes sig-
nificantly to binding and infection only by cell culture-adapted
strains. While infection with the AR339 consensus sequence
virus, TR339, was predominantly HS independent, four other
cell culture-adapted strains, each with mutations in the E2
gene, attached to cells through an HS-dependent mechanism.
These findings suggest that Sindbis virus rapidly mutates to
utilize HS during cell culture adaptation and that binding to
cell surface HS plays little or no role in interactions between
natural Sindbis virus isolates and cells in vivo. Our AR339
laboratory strain, TRSB, acquired a mutation conferring HS
attachment (Ser to Arg at E2 1) during single-step BHK cell
adaptation prior to cDNA cloning (40). Attachment of TRSB
was significantly increased relative to TR339 and was sensitive
to both heparinase I and heparinase III but was not saturable.
When TRSB was subjected to selection for rapid penetration
of BHK cells, an additional mutation conferring HS attach-
ment arose at E2 114 (Ser to Arg [11, 47]). Attachment of this
virus showed high affinity, was saturable, and was sensitive only
to heparinase III. The effect of E2 Arg 1 was independent of
the residue at E1 72, as shown in control binding and heparin
competition experiments using E2S1 (Table 1). Additionally,
passage of TR339 in BHK cells selected for a Glu-to-Lys mu-
tation at E2 70 that conferred high-affinity attachment to BHK
cells and to heparin-agarose beads.
While it has been known for some time that herpesviruses,
including herpes simplex virus (73), human cytomegalovirus
(10), bovine herpesvirus (45), and pseudorabies virus (41),
attach to HS during in vitro infection, it has only recently
become apparent that a number of other viruses can use this
molecule for cell attachment. Recent publications have impli-
cated HS in the in vitro attachment of type O foot-and-mouth
disease virus (FMDV) (29, 55), HIV (48, 52), respiratory syn-
cytial virus (34), porcine reproductive and respiratory syn-
drome virus (30), equine arteritis virus (1), Dengue virus (8),
adeno-associated virus (62), and vaccinia virus (9).
In the herpes simplex virus system, a protein that can me-
diate entry, but not attachment, has been identified (43). This
suggests that utilization of GAG molecules in virus infection
can result in a two-step entry process in which interaction with
the GAG molecule increases the concentration of the virus
ligand in the vicinity of its entry receptor, thereby enhancing
the overall efficiency of infection. That this model may be
generally applicable is supported by the studies of Wickham et
al. (72), who found that an HS binding sequence introduced
into the tip of the adenovirus fiber protein greatly increased
FIG. 7. Changes in titer, heparin competition, BHK cell binding, and hepa-
rin-agarose bead binding phenotypes of TR339 after passage in BHK cells. (A)
BHK cell monolayers were infected at a multiplicity of infection of 1 followed by
incubation for 20 h, harvesting of supernatants, and infection of new monolayers.
This cycle was repeated for a total of five passages. Hatched bars (left y axis)
indicate BHK cell titers for each of the five passages. The solid line (right y axis)
indicates change in inhibition of BHK cell plaque-forming efficiency due to
competition with soluble heparin (200 mg/ml). (B) Increases in BHK cell binding
(solid bars) and specific infectivity (hatched bars) of virus derived from the third
passage, compared to TR339 stock virus. (C) Increase in heparin-agarose bead
binding (solid bars) but not BSA-agarose bead binding (hatched bars) of third-
passage virus, compared to TR339 stock virus. p, binding of either virus to
BSA-agarose beads was ,1% of added cpm.
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infectivity of the virus for cell types that did not express a
high-affinity receptor. Our data do not clearly indicate whether
infection of HS-dependent Sindbis virus occurs in one or sev-
eral steps. It is clear that all of the viruses tested maintained a
low level of infectivity for cells lacking HS. This suggests that
infection can proceed without efficient binding and may reflect
the presence of an additional receptor(s).
Our results closely parallel those of Sa-Carvalho et al. (55)
with type O FMDV. In their studies, passage in culture was
associated with changes to positive amino acids at several po-
sitions in the capsid protein and acquisition of heparin-HS
attachment. The coselection for rapid penetration of BHK
cells, mutation in E2, and ability to attach to HS analogs also
has been documented for VEE in our laboratory (2). Thus,
adaptation to HS attachment may represent a common cell
culture-adaptive mechanism among alphaviruses. Our results
and those of Sa-Carvalho et al. may suggest further that adap-
tation to HS binding in cultured cells could occur in multiple
virus families. Therefore, studies of both virus attachment to
cultured cells and virus pathogenesis in vivo could be compro-
mised by the presence of such adaptive mutations embedded in
the genetic background of “wild-type” laboratory strains or
cloned viruses derived from them.
The relationship of our results to previous studies that have
identified different proteins as putative attachment receptors
for Sindbis virus on different cells (e.g., references 16, 37, and
69–71) is not clear. Cell surface chains of HS are generally
attached to proteoglycan core proteins (31). Moreover, HS
exhibits structural heterogeneity between cell types and is pre-
sented in different contexts on different cell types (e.g., through
attachment to different core proteins or in different protein-
proteoglycan-GAG complexes [4, 28, 31]). The heterogeneous
expression of HS and GAG chains on different cell types raises
the possibility for virus interaction with different HS-protein
structures on different cells and that cell-type-specific GAG or
proteoglycan core protein expression could regulate virus bind-
ing (3, 56). It is unknown whether any of the putative Sindbis
virus receptor proteins are full-time or facultative proteogly-
cans or whether any of these are intimately complexed with
proteoglycan-HS chains on cell surfaces. However, a major
conclusion from the results presented here is that single amino
acid differences between AR339 strains can dramatically alter
cell interaction properties. Therefore, it is quite possible that
unidentified structural glycoprotein differences between Sind-
bis virus laboratory strains account for the conflicting results
from different laboratories.
Domains involved in HS attachment. As defined by attach-
ment to BHK cells and heparin-agarose beads, mutation to a
positive charge at E2 1, E2 70, or E2 114 can independently
increase attachment affinity, suggesting that these mutations
may define three HS interaction domains on the glycoprotein
spike. Most protein-GAG binding is mediated by electrostatic
interaction between clusters of basic amino acids arranged in a
three-dimensional array on the ligand and a concentrated neg-
ative charge on the sulfated polysaccharide chain (reviewed in
reference 31). In an analysis similar to that undertaken by
Flynn and Ryan with pseudorabies virus protein gC (20), we
have scanned the PE2 and E1 glycoproteins for sequences that
conform to the XBBXBX and XBBBXXBBX (B, basic; X, any
amino acid) heparin interaction consensus motifs identified by
Cardin and Weintraub (7). The activity of these consensus
sequences is not dependent upon orientation (20). While no
close matches were found in E1, three close matches were
found in PE2 (Fig. 8).
One exact match comprised the XBXBBX furin protease
cleavage site of PE2 (14, 42; reviewed in reference 32), which
is immediately adjacent to the E2 Arg 1 mutation present in
both TRSB and TRSB-R114. Heidner et al. (25) have shown
that substitution of Arg, Ile, Val, or Asn for Ser at E2 1 reduces
PE2 cleavage efficiency, resulting in mature virus particles that
contain various amounts of PE2 and its associated furin cleav-
age-heparin binding site. Appropriate mutagenesis experi-
ments are currently in progress to test the hypothesis that BHK
cell binding is increased as a function of PE2-furin cleavage
site content in virions. Interestingly, the portion of the HIV V3
loop thought to interact with HS (52) contains a cluster of
positively charged amino acid residues comprising an occult
furin protease cleavage site that has been proposed to be
cleaved during HIV entry of cells (44).
The positively charged mutations at E2 70 and E2 114 were
not part of, or adjacent to, heparin interaction sequences.
Positive charge mutations in the E2 glycoprotein could in-
crease HS binding (i) by participating in conformationally de-
termined HS binding sites similar to those proposed for type O
strains of FMDV (55); (ii) by decreasing the efficiency of PE2
cleavage during virus maturation, thereby increasing the virion
content of uncleaved PE2 containing the heparin interaction
consensus motif; or (iii) by altering the conformation of virus
glycoprotein spikes, resulting in exposure of preexisting HS
interaction motifs.
In contrast to TRSB, the majority of binding of TRSB-R114
(mediated by E2 Arg 114) involves interaction with a specific
HS structure, as shown by binding saturation, xyloside precur-
sor reconstitution, and heparinase digestion experiments. This
is consistent with studies indicating that protein-HS interac-
tions can show significant HS sequence and sulfation specificity
(e.g., references 19 and 38). Further study will be required to
elucidate specific HS structures involved in interaction with
different Sindbis virus mutants.
Previous studies had indicated that virus attachment to cells
was not increased by the E2 Arg 114 mutation (47). Our results
may differ from those for two reasons. First, the criterion for
attachment in assays conducted by Olmsted et al. involved
resistance to removal by washing of plaque-forming virus
bound to cell monolayers, as opposed to the binding of radio-
labeled virus particles to cell suspensions, as reported here. We
have found that while these viruses exhibit large differences in
the amount of virus that attaches to cells, once virus particles
FIG. 8. Identification of heparin interaction consensus sequences (from ref-
erence 7) in the PE2 glycoprotein. Matches (XBBXBX or XBXBBX) are indi-
cated in boldface type within the glycoprotein sequence (residue numbers of the
amino-terminal consensus match residues are in boldface type below the se-
quence). E2 1, E2 70, and E2 114 mutations are indicated in boldface type above
the glycoprotein sequence. The site of furin protease cleavage of PE2 is indicated
by the arrow. Sequence matches adjacent to the transmembrane domain have not
been included.
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are attached they appear to be equally resistant to dislodging
by washing (data not shown). Secondly, viruses in the previous
assays were purified on potassium tartrate gradients. We have
found that this purification technique reduces the infectivity
and binding of TRSB-R114 preparations severalfold, perhaps
due to the detrimental effects of high ionic strength on virus
particles. This phenomenon also has been observed with a
VEE E2 glycoprotein mutant (12).
Relationship of HS attachment to neonatal mouse virulence.
Perhaps most interesting is that the primarily HS-independent
interaction of TR339 with cells is not saturable and is barely
measurable in a variety of cell binding assays. This result is
independent of cell type or temperature, is obtained when
binding assays are done with cell suspensions or monolayers,
and is consistent in both positive and subtractive binding assays
(data not shown). Nevertheless, TR339 is the most virulent of
the tested viruses in vivo (these studies; also references 33 and
65), suggesting that a weak, primarily HS-independent attach-
ment may represent an important component of alphavirus
entry in nature. TR339, TRSB, and TRSB-R114 exhibit indis-
tinguishable tissue tropisms in neonatal mice, differing only by
rate and extent of spread (33, 65). Therefore, the high-affinity
attachment of Sindbis virus laboratory strains, as typically mea-
sured in in vitro binding assays, may simply be a consequence
of adaptation to cultured cells and does not determine tissue
tropism in neonatal mice. However, this assertion is tempered
by the possibility that virus attachment in the context of an
intact organismal host may be very different from that mea-
sured in cell binding assays. For instance, in a number of virus
systems, particles may require activation by host factors for full
infectivity in vivo (reviewed in reference 32).
In separate studies (33, 65), it has been shown that attenu-
ation of TRSB and TRSB-R114 coincides with lower virus
titers in sera and brains of infected mice. Therefore, we suggest
that the HS attachment phenotype results in a general reduc-
tion in virus replication competence in vivo. A similar hypoth-
esis was recently proposed by Sa-Carvalho et al. for FMDV
(55), where tissue culture-adapted type O strains that had
acquired the ability to attach to HS were greatly reduced in
animal virulence. GAGs, and specifically HS molecules, com-
prise ubiquitous cell surface structures and also are abundant
components of extracellular matrices and basal laminae (re-
viewed in references 4, 28, 31, and 64). Consequently, it is
possible that HS attachment results in virus binding to unpro-
ductive receptor structures in vivo. In addition, HS attachment
may affect virus replication competence by interfering with
virus particle release from cells. We have observed that virus
particle production from individual infected BHK cells is in-
versely correlated with HS attachment efficiency (data not
shown). We are currently investigating whether a combination
of inappropriate receptor targeting and reduced particle re-
lease may determine neonatal mouse virulence of Sindbis vi-
ruses that have adapted to attach to HS.
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